This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Browse our events, training, articles and people by topicclose

Popular sectors

A - Z

Browse Topicsappsclose
search

Antibody Engineering

Find the latest science, technology and partners in antibody engineering, immunobiology and next generation binders.

Events

Showing 5 of 7 eventsView all events
Featured

Antibody Engineering & Therapeutics Asia

24-26 February 2021, Kyoto, Japan

THE ONLY EVENT IN ASIA PROVIDING THE LATEST SCIENCE, TECHNOLOGY AND PARTNERS TO ACCELERATE ANTIBODY & PROTEIN THERAPIES, ADCS, BISPECIFICS AND IMMUNO-ONCOLOGY

Go to site

Antibody Engineering & Therapeutics Europe

24-27 August 2020, Delivered in Central European Summer Time (CEST) and On-Demand

THE INDUSTRY’S EUROPEAN EVENT FOR ANTIBODY AND PROTEIN THERAPEUTIC SCIENCE, TECHNOLOGY AND NETWORKING

Antibody Engineering & Therapeutics Europe (Booking Form 2)

24-27 August 2020, Virtual Event

Next Generation Bioconjugates Summit

November 2-4, 2020, San Francisco, CA

Accelerate your antibody drug & novel conjugate pipelines from early discovery to late stage development

Antibody Engineering & Therapeutics US

December 13-17, 2020, San Diego, CA

THE #1 ANTIBODY ENGINEERING CONFERENCE FOR ACCELERATING NEXT GENERATION ANTIBODIES TO COMMERCIAL SUCCESS

Articles & Video

Showing 9 of 43 articles & videoView all articles & video
Premium
Antibodies

Emerging Therapies Content Library: Whitepapers and Reports Collection

Explore our collection of exclusive whitepapers and reports covering the most exciting developments in emerging therapies with one simple registration.

Featured
COVID-19

Future Trends in Proteins To Fight COVID-19

The whitepaper presents new case studies exposing the growing opportunities in protein therapeutics to treat COVID-19.

Premium
EBook

The Future of Antibody Engineering and Therapeutics - eBook Series

In the first of our Antibody Therapeutics eBook Series, we take an in-depth look at how the latest technologies and strategies are shaping the future of the industry.

COVID-19

80% of life sciences professionals predict a COVID-19 vaccine will be approved within 18 months

How quickly to life sciences professionals predict a COVID-19 vaccine will be approved and what are the main obstacles? We explore.

Bispecific Antibodies

Podcast: How to Create the Ultimate Bispecific

Life Sciences

The biggest breakthroughs in life sciences the last 10 years

Bioconjugates

Strategies to Innovate the Production of Next Generation Bioconjugates

Premiumget_app
Diversity and Inclusion

Diversity in the life sciences workplace: Implementing a leading corporate culture for innovation - WHITEPAPER

Research Report

REPORT: Antibody Therapeutic Modalities 2020

SPONSORSHIP & EXHIBITION OPPORTUNITIES

There are many ways for your organisation to engage a qualified audience of 35,000+ antibody executives and scientists, including 2,100+ annual attendees gathered across the globe! Share your strategy and plans so we can help you identify the best opportunities to reach your objectives. Our team will collaborate with you to develop a bespoke program tailored to your unique needs.

To find out more, contact Kristin Skahan, Head of Portfolio Sales: 

kristin.skahan@informa.com | +1-857-504-6730

All opportunities can be customised to align with your needs and budget. Examples may include:

  • Exhibition space
  • Speaking slots and onsite video interviews
  • High-impact branding and messaging
  • Private/public hosted events (lunches, breakfasts, and receptions)
  • Custom digital campaigns
DOWNLOAD 2020 SPONSOR PROSPECTUS

Copyright © 2020 Informa Connect Limited. Registered in England & Wales with number 01835199, registered office 5 Howick Place, London, SW1P 1WG.